Cargando…
Nanoparticles Mimicking Viral Cell Recognition Strategies Are Superior Transporters into Mesangial Cells
Poor drug availability in the tissue of interest is a frequent cause of therapy failure. While nanotechnology has developed a plethora of nanocarriers for drug transport, their ability to unequivocally identify cells of interest remains moderate. Viruses are the ideal nanosized carriers as they are...
Autores principales: | Maslanka Figueroa, Sara, Fleischmann, Daniel, Beck, Sebastian, Tauber, Philipp, Witzgall, Ralph, Schweda, Frank, Goepferich, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7284201/ https://www.ncbi.nlm.nih.gov/pubmed/32537398 http://dx.doi.org/10.1002/advs.201903204 |
Ejemplares similares
-
Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-β Pathway
por: Fleischmann, Daniel, et al.
Publicado: (2021) -
Thermodynamic, Spatial and Methodological Considerations for the Manufacturing of Therapeutic Polymer Nanoparticles
por: Maslanka Figueroa, Sara, et al.
Publicado: (2020) -
Biomedical nanoparticle design: What we can learn from viruses
por: Maslanka Figueroa, Sara, et al.
Publicado: (2021) -
T Cell Membrane Mimicking Nanoparticles with Bioorthogonal Targeting and Immune Recognition for Enhanced Photothermal Therapy
por: Han, Yutong, et al.
Publicado: (2019) -
GAP JUNCTIONS IN MESANGIAL AND LACIS CELLS
por: Pricam, Claude, et al.
Publicado: (1974)